accountof 43 cents a share. Revenue fell about 7% to $2.5 billion. DRUGS Allergan sues rival Watson Allergan Inc.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ALLERGAN INC.
Allergan, Inc. is a global, multi-specialty healthcare company that operates in two business segments: specialty pharmaceuticals and medical devices. Their products include ophthalmic pharmaceuticals, dermatology products, and neurological products. Allergan, Inc.’s most notable product is Botox, which is used for therapeutic and aesthetic indications. The company was founded in 1948 and is headquartered in Irvine, California.
Allergan Inc. is part of Business Exchange, suggested by
Ulli Muenker.
This topic contains
244 news
and
82 blog
items.
Read updated news, blogs, and resources about Allergan Inc.. Find user-submitted articles and reactions on Allergan Inc. from
like-minded professionals.
News
Please add new articles to this topic
for its topical and injectable neurologic compounds and TransMTS delivery technology. Botox® Cosmetic is a registered...
Solvay SA's (SOLB.BR) testosterone gel Androgel, Schering-Plough Corp's asthma drug (SGP.N) Asmanex (mometasone...
-- swells because of fluid accumulation from leaking or blocked retinal veins. In a news release, device maker...
BOSTON (MarketWatch) -- Allergan Inc. (agn) said Thursday that it has won U.S. regulatory approval for its eye...
Among other recent sales, the Southern California-focused real estate investment trust completed a $22-million...
VIDEO: Allergan, Inc. Announces the 'BOTOX(R) Cosmetic: Express Success' Charitable Education Campaign, Committing...
Drug stocks climbed into positive territory with the broader market early Monday, with Allergan Inc. blazing the trail.
to portfolio Analyst Create alert Insider Discuss Financials Sponsored by: , , ) was up about 60 points at 8,273.
Allergan Inc., maker of the wrinkle-smoother Botox, reported Friday that its first-quarter profit fell 58% as the...
Botox sales fall 5.8 percent * Total revenue down 6 percent NEW YORK, May 1 (Reuters) - Allergan Inc (AGN.
IRVINE, Calif. - Botox maker Allergan Inc. said Friday its first-quarter profit fell 59 percent on a series of...
Key Note Speaker: Robert E. Grant, President, Allergan Medical Mr. Robert E. Grant, 39, joined Allergan, Inc.
* Botox sales fall 18 percent * Total revenue down 6 percent NEW YORK (Reuters) - Allergan Inc said Friday its...
reported * Allergan shares fall 2.6 percent (Adds FDA quotes, updates shares) WASHINGTON, April 30 (Reuters) - Allergan...
affected users had taken the drug to treat limb spasticity associated with cerebral palsy. Botox is marketed by...
NYSE:SNY) and Novartis, but we should not rule out (NYSE: JNJ) or GlaxoSmithKline, if its acquisition of Allergan Inc.
Industrial Average tumbled about 240 points, or 3%, to 7,892. Leading decliners among the large caps included Allergan...
Industrial Average tumbled about 240 points, or 3%, to 7,892. Leading decliners among the large caps included Allergan...
at Dey, Engle also served as Regional Director, North America, for the Merck Generics Group. He was with Allergan, Inc.
Liposuction, Blepharoplasty, and Rhinoplasty. The report profiles 78 companies including many key and niche players...
IRVINE, Calif.--(Business Wire)-- Allergan, Inc. (NYSE:AGN) invites you to listen to David Pyott, Chairman of the Board...
is a registered trademark of RIT Oncology LLC, a subsidiary of Spectrum. EOquin is a registered trademark of Allergan,...
Foundation(R) Register on LATISSE(TM) Web Site to Help Reach Goal IRVINE, Calif., March 27 /PRNewswire-FirstCall/ --...
Shares of Allergan Inc. rose 13% on Tuesday on speculation the maker of Botox might be bought. Allergan surged $5.
Top Sources: Allergan Inc.
- grinza.com
- Reuters
- MarketWatch
- TheDeal.com
- ocbj.com
- Wall Street Journal Online
- BusinessWeek
- Los Angeles Times
- Morningstar.com
- CNN Money
